middle.news
Neuren Publishes Promising Phase 2 Data as Phase 3 Koala Trial Recruits PMS Patients
10:42am on Wednesday 7th of January, 2026 AEDT
•
Healthcare
Read Story
Neuren Publishes Promising Phase 2 Data as Phase 3 Koala Trial Recruits PMS Patients
10:42am on Wednesday 7th of January, 2026 AEDT
Key Points
Phase 2 trial results published in Neurology® Genetics
NNZ-2591 well-tolerated with meaningful symptom improvements
Phase 3 Koala trial recruiting children aged 3 to 12 in the US
FDA granted Fast Track, Rare Pediatric Disease, and Orphan Drug designations
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neuren Pharmaceuticals (ASX:NEU)
OPEN ARTICLE